Cargando…
The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum
AIM: The purpose of this qualitative study was to investigate the effects experienced by users of a novel psychoactive substance, the benzodiazepine flubromazolam, by analysing users’ own accounts on the Swedish forum Flashback.org. METHOD: A thematic analysis of anonymous self-reports published on...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450873/ https://www.ncbi.nlm.nih.gov/pubmed/32934486 http://dx.doi.org/10.1177/1455072517706304 |
_version_ | 1783574878720360448 |
---|---|
author | Andersson, Martin Kjellgren, Anette |
author_facet | Andersson, Martin Kjellgren, Anette |
author_sort | Andersson, Martin |
collection | PubMed |
description | AIM: The purpose of this qualitative study was to investigate the effects experienced by users of a novel psychoactive substance, the benzodiazepine flubromazolam, by analysing users’ own accounts on the Swedish forum Flashback.org. METHOD: A thematic analysis of anonymous self-reports published on the forum was performed and generated five general themes describing effects and experiences by flubromazolam users. RESULTS: The themes which emerged were: Onset and duration, Desired effects, Adverse effects and addiction, Loss of control, General estimations and evaluations. The main reported characteristics of flubromazolam were heavy hypnotic and sedative effects, long-lasting amnesiac effects and the rapid development of tolerance. Flubromazolam was also anxiolytic and acted as a muscle relaxant for many users. Some users experienced euphoria or intense wellbeing. Other prominent characteristics were loss of control (leading to poor choices and actions, with unpleasant consequences) and long-lasting, often severe withdrawals. There were also serious incidents where users had been admitted to hospital, acute psychiatric treatment or taken into custody by the police. CONCLUSION: Flubromazolam appears to be a highly addictive and precarious benzodiazepine with many, possibly severe, side effects. The substance is generally described as very potent and with long-lasting effects. Memory loss and loss of control are common adverse effects, and withdrawals appear to be severe for many users. |
format | Online Article Text |
id | pubmed-7450873 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-74508732020-09-14 The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum Andersson, Martin Kjellgren, Anette Nordisk Alkohol Nark Research Reports AIM: The purpose of this qualitative study was to investigate the effects experienced by users of a novel psychoactive substance, the benzodiazepine flubromazolam, by analysing users’ own accounts on the Swedish forum Flashback.org. METHOD: A thematic analysis of anonymous self-reports published on the forum was performed and generated five general themes describing effects and experiences by flubromazolam users. RESULTS: The themes which emerged were: Onset and duration, Desired effects, Adverse effects and addiction, Loss of control, General estimations and evaluations. The main reported characteristics of flubromazolam were heavy hypnotic and sedative effects, long-lasting amnesiac effects and the rapid development of tolerance. Flubromazolam was also anxiolytic and acted as a muscle relaxant for many users. Some users experienced euphoria or intense wellbeing. Other prominent characteristics were loss of control (leading to poor choices and actions, with unpleasant consequences) and long-lasting, often severe withdrawals. There were also serious incidents where users had been admitted to hospital, acute psychiatric treatment or taken into custody by the police. CONCLUSION: Flubromazolam appears to be a highly addictive and precarious benzodiazepine with many, possibly severe, side effects. The substance is generally described as very potent and with long-lasting effects. Memory loss and loss of control are common adverse effects, and withdrawals appear to be severe for many users. SAGE Publications 2017-05-16 2017-06 /pmc/articles/PMC7450873/ /pubmed/32934486 http://dx.doi.org/10.1177/1455072517706304 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Research Reports Andersson, Martin Kjellgren, Anette The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum |
title | The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum |
title_full | The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum |
title_fullStr | The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum |
title_full_unstemmed | The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum |
title_short | The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum |
title_sort | slippery slope of flubromazolam: experiences of a novel psychoactive benzodiazepine as discussed on a swedish online forum |
topic | Research Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450873/ https://www.ncbi.nlm.nih.gov/pubmed/32934486 http://dx.doi.org/10.1177/1455072517706304 |
work_keys_str_mv | AT anderssonmartin theslipperyslopeofflubromazolamexperiencesofanovelpsychoactivebenzodiazepineasdiscussedonaswedishonlineforum AT kjellgrenanette theslipperyslopeofflubromazolamexperiencesofanovelpsychoactivebenzodiazepineasdiscussedonaswedishonlineforum AT anderssonmartin slipperyslopeofflubromazolamexperiencesofanovelpsychoactivebenzodiazepineasdiscussedonaswedishonlineforum AT kjellgrenanette slipperyslopeofflubromazolamexperiencesofanovelpsychoactivebenzodiazepineasdiscussedonaswedishonlineforum |